14 results
20-F
2021 FY
VALN
Valneva SE
24 Mar 22
Annual report (foreign)
12:32pm
to identify or access. This may be due in part to reputational challenges that the vaccine industry is facing related to the growing momentum of the anti … vaccines and therapies;
the existence of alternative therapies;
the public perception of new therapies and the reputational challenges that the vaccine
424B4
VALN
Valneva SE
1 Nov 21
Prospectus supplement with pricing info
4:06pm
. This may be due in part to reputational challenges that the vaccine industry is facing related to the growing momentum of the anti-vaccine movement … to alternative vaccines and therapies;
the existence of alternative therapies;
the public perception of new therapies and the reputational challenges
F-1
VALN
Valneva SE
26 Oct 21
Registration statement (foreign)
5:04pm
or access. This may be due in part to reputational challenges that the vaccine industry is facing related to the growing momentum of the anti-vaccine movement … to alternative vaccines and therapies;
the existence of alternative therapies;
the public perception of new therapies and the reputational
DRS
1xiyi0s7bpue1
20 Oct 21
Draft registration statement
12:00am
424B4
aju c2i0xpifxhjpnm
7 May 21
Prospectus supplement with pricing info
4:06pm
F-1/A
xdsqij28i8zrtzpydy
5 May 21
Registration statement (foreign) (amended)
6:07am
F-1/A
2902zu8nr
29 Apr 21
Registration statement (foreign) (amended)
6:08am
F-1/A
ubb4icpedlh88ffo6b
21 Apr 21
Registration statement (foreign) (amended)
5:06pm
F-1
ksf3iunb24c851mph7
9 Apr 21
Registration statement (foreign)
4:06pm
DRS/A
bifbi
24 Mar 21
Draft registration statement (amended)
12:00am
DRS/A
wjtxumjrje4q
24 Feb 21
Draft registration statement (amended)
12:00am
DRS
fl82i2yppgj6e0o84
15 Jan 21
Draft registration statement
12:00am
- Prev
- 1
- Next